Syngene International Limited’s stock continued to face selling pressure on April 25, 2025, trading at ₹641.30, down ₹12.10 or 1.85% from the previous close of ₹653.40. The stock opened slightly higher at ₹655.00 and touched an intraday high of ₹657.00, but quickly lost momentum and dipped to a low of ₹638.00.
The stock’s movement reflects continued bearish sentiment following the sharp 10% fall in the previous session.
Syngene International reported a 3% year-on-year decline in its quarterly net profit, coming in at ₹183 crore for the March quarter.
The dip was attributed to a one-off inventory adjustment for a key client and ongoing pressure on margins.
The company also highlighted short-term challenges due to a fluid macroeconomic backdrop and the ongoing integration of recent investments, which are affecting profitability.
Despite profit headwinds, Syngene’s revenue crossed the ₹1,000-crore mark for the first time, posting ₹1,018 crore—an 8% sequential rise and an 11% increase year-on-year.
However, in line with a cautious stance, the company has revised its revenue growth guidance for FY26 to the early teens. This follows an earlier downgrade in Q3, from high-single-digit growth to single digits, reflecting a conservative outlook moving forward.
Syngene International Ltd is an innovation-driven contract research, development, and manufacturing organisation that provides integrated scientific services across the entire product lifecycle, from early discovery to commercial supply.
With a focus on customised, end-to-end solutions, Syngene collaborates closely with clients to offer R&D and manufacturing services that go beyond traditional outsourcing.
The company serves a wide range of industries, including pharmaceuticals, biotechnology, and life sciences, and is known for its cutting-edge capabilities in biologics, small molecules, and complex biologics manufacturing.
Read More: Waaree Energies Shares Drop Nearly 9% as Lock-In Period Ends for Major Stake.
Syngene International’s recent stock slide reflects heightened investor caution amid weaker-than-expected profit performance and a conservative growth outlook.
Despite steady revenue growth and milestone achievements in Q4 FY25, short-term margin pressures and external economic uncertainties have weighed on market sentiment. Investors may continue to monitor how the company navigates these headwinds and integrates its recent investments in the quarters ahead.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Apr 25, 2025, 10:39 AM IST
Neha Dubey
Neha Dubey is a Content Analyst with 3 years of experience in financial journalism, having written for a leading newswire agency and multiple newspapers. At Angel One, she creates daily content on finance and the economy. Neha holds a degree in Economics and a Master’s in Journalism.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
